Therapeutic Advances in Hematology

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Hematology is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
2040-6207 · 2040-6215
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,650 USD
Articles in DOAJ
467
Declared review time
7 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2019-07-23
Indexing
DOAJ
APC
2,650 USD
Declared review time (DOAJ)
7 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

467

Most recent article

last month

Average review time (journal-declared via DOAJ)

7weeks

Works in OpenAlex

681

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

55

i10-index

343

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-04
Added to DOAJ
2019-07-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPorticoScholars Portal
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
93%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
TAH
Source type
journal
NLM unique ID (PubMed)
101549589
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

LCC codes

RC633-647.5

Subject areas

  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
Show all subjects (50)
  • CAR-T cell therapy research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • Platelet Disorders and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Platelet Disorders and Treatments
  • Hemophilia Treatment and Research
  • Hemophilia Treatment and Research
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood Coagulation and Thrombosis Mechanisms
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Immunodeficiency and Autoimmune Disorders
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Immunodeficiency and Autoimmune Disorders
  • Immune Cell Function and Interaction
  • Complement system in diseases
  • Immune Cell Function and Interaction
  • Complement system in diseases

Keywords (DOAJ)

  • blood disorders
  • blood diseases
  • haematology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: